⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL129248 | 0.88 | — | — | |
| SCHEMBL977269 | 0.82 | — | — | |
| SCHEMBL975083 | 0.82 | — | — | |
| SCHEMBL5417902 | 0.82 | — | — | |
| SCHEMBL5416734 | 0.82 | — | — | |
| SCHEMBL130460 | 0.79 | — | — | |
| SCHEMBL17911642 | 0.69 | — | — | |
| SCHEMBL146255 | 0.62 | — | — | |
| SCHEMBL3185118 | 0.62 | — | — | |
| Ammonia Solution, Strong SCHEMBL10841501 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 447 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12005054-B2 | Piperidinyl-3-(aryloxy)propanamides and propanoates | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2024-06-11 | — | — | US | claimed |
| CN-112236423-B | Piperidinyl-3- (aryloxy) propanamides and propionic acid esters | 武田药品工业株式会社 | 2024-02-06 | — | — | CN | claimed |
| US-20230021834-A1 | PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-01-26 | — | — | US | claimed |
| US-11045457-B2 | Piperidinyl-3-(aryloxy)propanamides and propanoates | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2021-06-29 | — | — | US | claimed |
| CN-112236423-A | Piperidinyl-3- (aryloxy) propanamides and propionates | 武田药品工业株式会社 | 2021-01-15 | — | — | CN | claimed |
| US-20200061041-A1 | PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2020-02-27 | — | — | US | claimed |
| US-9809711-B2 | Catalyst and formulations comprising same for alkoxysilanes hydrolysis reaction in semiconductor process | VERSUM MATERIALS US, LLC (US) | 2017-11-07 | — | — | US | claimed |
| EP-2618364-A2 | Catalyst and formulations comprising same for alkoxysilanes hydrolysis reaction in semiconductor process | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2013-07-24 | — | — | EP | claimed |
| US-20130180215-A1 | CATALYST AND FORMULATIONS COMPRISING SAME FOR ALKOXYSILANES HYDROLYSIS REACTION IN SEMICONDUCTOR PROCESS | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2013-07-18 | — | — | US | claimed |
| EP-1581477-B1 | CYCLOALKENE DICARBOXYLIC ACID COMPOUNDS AS ANTI-INFLAMMATORY, IMMUNOMODULATORY AND ANTI-PROLIFERATORY AGENTS | 4SC AG (DE) | 2009-12-02 | — | — | EP | claimed |
| US-6309796-B1 | PHOTORESISTS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2001-10-30 | — | — | US | claimed |
| US-4831013-A | BENZODIAZEPINE RECEPTOR ANTAGONISTS | CIBA-GEIGY CORPORATION (US) | 1989-05-16 | — | — | US | claimed |
| US-12043702-B2 | Polymer, composition, molded article, cured product and laminate | JSR CORPORATION (JP) | 2024-07-23 | — | — | US | disclosed |
| WO-2024142925-A1 | SEMICONDUCTOR SUBSTRATE PRODUCTION METHOD, COMPOSITION, AND POLYMER | JSR株式会社 | 2024-07-04 | — | — | WO | disclosed |
| US-12005054-B2 | Piperidinyl-3-(aryloxy)propanamides and propanoates | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2024-06-11 | — | — | US | disclosed |
| WO-2024116576-A1 | RADIATION-SENSITIVE RESIN COMPOSITION, PATTERN FORMATION METHOD, AND RADIATION-SENSITIVE ACID-GENERATING AGENT | JSR株式会社 | 2024-06-06 | — | — | WO | disclosed |
| US-20020058205-A1 | High molecular weight silicone compounds, resist compositions, and patterning method | NAKASHIMA MUTSUO (JP) | 2002-05-16 | — | — | US | disclosed |
| US-6344471-B1 | DIISOPROPYL FLUOROPHOSPHATE (DFP), TREATMENT OF COGNITIVE DISORDERS, DEPRESSION, SCHIZOPHRENIA AND ANXIETY. | BAYER AKTIENGESELLSCHAFT (DE) | 2002-02-05 | — | — | US | disclosed |
| EP-1087950-A1 | NEW 2-AMINOCARBONYL-5(2H)-ISOXAZOLONES AS LIGANDS OF A DFP-BINDING SITE FOR TREATMENT OF CNS-DISEASES | BAYER AG (DE) | 2001-04-04 | — | — | EP | disclosed |
| WO-1999067229-A1 | NEW 2-AMINOCARBONYL-5(2H)-ISOXAZOLONES AS LIGANDS OF A DFP-BINDING SITE FOR TREATMENT OF CNS-DISEASES | BAYER AKTIENGESELLSCHAFT (DE) | 1999-12-29 | — | — | WO | disclosed |